OGD partially updated its Generic Drugs Activity Report for FY 2016 this morning and it must have found a few more receipts.  In our Monday post (here), we reported 175 receipts of new original ANDAs.  That number was revised upward to 180 by OGD today.  The straight line average would then project to 1032 ANDAs but it is not likely that the rate of 180 per month will be sustained. At least I am certain OGD hopes not.